CARCINOMA
Clinical trials for CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA trials appear
Sign up with your email to follow new studies for CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: CARCINOMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Brain tech and VR join forces to fight cancer pain
Knowledge-focused TerminatedThis study explored new ways to measure and manage pain in cancer patients and survivors. Researchers used a non-invasive brain imaging technique (fNIRS) to see how the brain reacts to pain and tested whether virtual reality (VR) could help reduce pain and the need for pain medic…
Matched conditions: CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC